BiotechTube
Home/Kamari Pharma/David Aviezer, PhD, MBA
DA

David Aviezer, PhD, MBA

CEO

Kamari Pharma

Therapeutic Areas

DermatologyRare Diseases

Kamari Pharma Pipeline

DrugIndicationPhase
KM-001Palmoplantar Keratoderma, Olmsted Syndrome, IchthyosisPhase 1
KM-023Severe Keratoderma and IchthyosisPreclinical

Leadership Team at Kamari Pharma

LB
Liora Braiman, PhD
Chief Scientific Officer
AY
Asaf Yarkoni, CPA
Chief Financial Officer
DM
Dayana Michel, MD
SVP Medical and Clinical Affairs
View full Kamari Pharma profile